News2 mins ago
ISA Pharmaceuticals to Present First Clinical Trial Data from the Phase II Study of ISA101b and Libtayo® (cemiplimab) Combination in Head and Neck Cancer at the ASCO Annual Meeting 2023
– Dr. Anthony Kong (Guy’s and St Thomas’ Hospitals, London), Principal Investigator, will present data from ProcemISA, an ongoing clinical trial in anti-PD1 resistant advanced head...
